Scandinavian Real Heart AB (Publ) (HEART.ST) Stock Analysis & Winston Score
Scandinavian Real Heart AB is a Swedish medical device company working to build a total artificial heart — a mechanical device designed to replace a failing human heart entirely. Its main product is the Total Artificial Heart (TAH), aimed at patients with severe heart failure who cannot survive long enough to receive a donor heart transplant. The company is in the research and development stage and sells no commercial products yet. Real Heart earns no meaningful revenue today, as it is still conducting preclinical and early clinical testing of its device. It operates primarily in Sweden and is a very small company with a market cap around $100 million. The core risk is significant: developing a medical device this complex requires years of regulatory approvals, large amounts of ongoing funding, and successful human clinical trials — none of which are guaranteed. Investors are essentially betting on whether the company can clear those hurdles before running out of money.
Winston Score: 0/100 — Insufficient Data
Not enough data to score this stock reliably.
- Quality: Weak (0/30)
- Growth: Mixed (5/20)
- Cash Flow: Data not available (0/10)
- Stability: Good (5/10)
- Valuation: Data not available (0/10)
- Ownership: Good (10/15)

